Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis
The impact of a 4-week course of therapy with Uralyt-U (potassium-sodium hydrocitrate) on uric acid (UA) metabolic parameters was studied in patients with gout and nephrolithiasis. Elevated daily urinary excretion of UA was found to be directly correlated with its lower serum level after 4-week ther...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
IMA-PRESS LLC
2012-03-01
|
| シリーズ: | Современная ревматология |
| 主題: | |
| オンライン･アクセス: | https://mrj.ima-press.net/mrj/article/view/400 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|